Air Pollution with particulate matter about 2.5 micron increases lung damage: JAMA
A new study published in the Journal of American Medical Association shows that sulfate, ammonium, and nitrate elements of Particulate matter 2.5 (PM2.5) were linked to the most damage and were associated with baseline severity, illness progression, and death among patients with fibrotic interstitial lung diseases (fILDs), underscoring the need for reductions in pollution from human sources.
Particulate matter with a diameter of 2.5 m or less is linked to poor outcomes for people with idiopathic pulmonary fibrosis, but its links to other fibrotic interstitial lung conditions and the composition of PM2.5 are yet unknown. As a result, Gillian Goobie and colleagues carried out this study to look at the relationship between fILD patients' exposure to PM2.5 and their mortality and lung function.
Patients in this worldwide multicenter, prospective cohort research were enrolled in the Simmons Center for Interstitial Lung Disease Registry at the University of Pittsburgh in Pittsburgh; 42 sites of the Pulmonary Fibrosis Foundation Registry; and 8 sites of the Canadian Registry for Pulmonary Fibrosis. A total of 6683 individuals with fILD were enrolled in the study. The data was examined from June 1, 2021 to August 2, 2022. PM2.5 and constituent exposure was calculated using hybrid models that used satellite-derived aerosol optical depth, chemical transport models, and ground-based PM2.5 observations.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.